Kerckhoff Klinik
Bad Nauheim, 61231, Germany
NCT Number: NCT04111744
Patients (pts) with stable coronary artery disease (CAD) requiring coronary artery bypass graft surgery (CABG) may be physically inactive during the waiting period to avoid further risks. Aim of this study is to investigate the feasibility and safety of a preoperative aerobic exercise training in these pts during the waiting period and to analyze its effects on pre-, peri and postoperative outcomes
Looking for future studies?
Notify Me50 year and older
All sexes
Interventional
Not applicable
Bad Nauheim, 61231, Germany
Pts with stable coronary artery disease (CAD) and indication for elective CABG will be prospectively randomized into a preoperative training group (TG) or a non active control group (CG). Pts in TG have to perform six sessions of aerobic endurance training within two weeks prior to CABG. The following investigations will be performed at baseline, one day before surgery and at the beginning and at the end of cardiac rehabilitation: a maximal symptom limited ergospirometry, assessment of endothelial function (analysing the reactive hyperaemic index (RHI) via a finger-tonometry), assessment of quality of life (QoL) using the MacNew Heart Disease Questionnaire, laboratory testing of ischemic and inflammatory Parameters. Baseline, peri- and postoperative characteristics will be collected.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients undergoing CABG and randomized to the Training Group complete six sessions of aerobic endurance training prior CABG surgery
Standard medication for stable CAD
Time frame: Baseline, prior surgery on hospital admission day, hospital discharge day ( postoperative day 7-14) , after 3 weeks of cardiac rehabilitation
Change of maximal Oxygen consumption
Time frame: Baseline, prior surgery on hospital admission day, hospital discharge day (postoperative day 7-14), after 3 weeks of cardiac rehabilitation
Change of Reactive hyperemic index (RHI)
Time frame: Within the acute care period
Duration of hospital stay in days
Time frame: Within the acute care period
Duration of Ventilation in minutes
Time frame: Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Change of 6-minute walk test
Time frame: Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Changes in arterial pulse wave analysis
Time frame: Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Changes in MacNew (Heart Disease Health-related Quality of Life-) Questionnaire questionaire
Time frame: Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Changes in Hospital Anxiety and Depression Scale (HADS) questionnaire: The HADS is a fourteen item scale that generates ordinal data.Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression.
Time frame: Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Changes in Mobility and Self-supply (MOSES) questionnaire
Time frame: Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
High Sensitive Troponin (hs-Trop)
Time frame: Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Creatine kinase (CK) U/L
Time frame: Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Creatine Kinase-MB (CK-MB) U/L
Time frame: Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Lactate dehydrogenase (LDH) U/L
Time frame: Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
glutamic oxaloacetic transaminase (GOT) U/L
Time frame: Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
glutamate pyruvate transaminase (GPT) U/L
Time frame: Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
copeptin U/L
Time frame: Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
C-reactive protein (CRP) U/L
Time frame: Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Leucozytes 10³/µL
Time frame: Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Interleukine-6 (IL-6) pg/mL
Time frame: Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Atrial fibrillation documented by electrocardiogram (ECG)
Time frame: Baseline, prior surgery on hospital admission day, hospital discharge day(postoperative day 7-14), , after 3 weeks of cardiac rehabilitation
Pleural effusion, pulmonary infection or other pulmonary disorder with Need for treatment
Time frame: after 30 days and 12 months
Revascularization, re-CABG, rehospitalization due to unstable angina, myocardial infarction
Time frame: after 30 days and 12 months
TIA, stroke
Kerckhoff Klinik
Other
Preoperative Excercise Training for Patients Undergoing Coronary Artery Bypass Graft Surgery- A Prospective Randomized Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04663373
Arterial Occlusive Diseases, Arteriosclerosis
Bern, Switzerland
View Trial DetailsNCT06759805
Adherence, Medication, Adherence, Treatment
Bergen, Norway
View Trial DetailsNCT03711539
Arrhythmias, Cardiac, Arterial Occlusive Diseases
Edegem, Belgium
View Trial DetailsNCT01294163
Arterial Occlusive Diseases, Arteriosclerosis
Bron, France
View Trial Details